173 related articles for article (PubMed ID: 23483489)
1. Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma.
Ye L; Guan S; Zhang C; Lee KH; Sun S; Wei J; Liu B
Tumour Biol; 2013 Jun; 34(3):1873-7. PubMed ID: 23483489
[TBL] [Abstract][Full Text] [Related]
2. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma.
Guan S; Liu B; Zhang C; Lee KH; Sun S; Wei J
Clin Transl Oncol; 2013 Oct; 15(10):825-9. PubMed ID: 23423807
[TBL] [Abstract][Full Text] [Related]
3. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
4. Circulating autoantibody to ABCC3 may be a potential biomarker for esophageal squamous cell carcinoma.
Cheng Y; Xu J; Guo J; Jin Y; Wang X; Zhang Q; Liu L
Clin Transl Oncol; 2013 May; 15(5):398-402. PubMed ID: 23054755
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
[TBL] [Abstract][Full Text] [Related]
6. Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer.
Jin Y; Guan S; Liu L; Sun S; Lee KH; Wei J
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e37-41. PubMed ID: 24811068
[TBL] [Abstract][Full Text] [Related]
7. Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer.
Zhao H; Zhang X; Han Z; Xie W; Yang W; Wei J
Sci Rep; 2018 Jun; 8(1):9847. PubMed ID: 29959381
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
[TBL] [Abstract][Full Text] [Related]
9. FOXP3 autoantibody as a potential early prognostic serum biomarker in patients with cervical cancer.
Xu S; Huangfu M; Jia X; Song X; Sun B; Lee KH; Liu L; Sun S
Int J Clin Oncol; 2015 Oct; 20(5):982-8. PubMed ID: 25681877
[TBL] [Abstract][Full Text] [Related]
10. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
Gao SG; Yang JQ; Ma ZK; Yuan X; Zhao C; Wang GC; Wei H; Feng XS; Qi YJ
BMC Cancer; 2018 Jan; 18(1):17. PubMed ID: 29298684
[TBL] [Abstract][Full Text] [Related]
12. Study of circulating antibodies against CD25 and FOXP3 in breast cancer.
Liu T; Song YN; Shi QY; Liu Y; Bai XN; Pang D
Tumour Biol; 2014 Apr; 35(4):3779-83. PubMed ID: 24347486
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
Sun G; Ye H; Wang X; Li T; Jiang D; Qiu C; Dai L; Shi J; Wang K; Song C; Wang P; Zhang J
Cancer Med; 2020 Feb; 9(3):1173-1182. PubMed ID: 31856412
[TBL] [Abstract][Full Text] [Related]
14. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
[TBL] [Abstract][Full Text] [Related]
15. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?
Liu L; Liu N; Liu B; Yang Y; Zhang Q; Zhang W; Yu P; Jin Y; Guo J; Guan S; Sun S; Miao L; Wei J
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1737-42. PubMed ID: 22699933
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of serum tumor-associated autoantibodies in esophageal cancer.
Xiao K; Ma X; Wang Y; Zhu C; Guo L; Lu R
Biomark Med; 2021 Oct; 15(15):1333-1343. PubMed ID: 34541870
[No Abstract] [Full Text] [Related]
17. Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma.
Li L; Liu M; Lin JB; Hong XB; Chen WX; Guo H; Xu LY; Xu YW; Li EM; Peng YH
Dis Markers; 2017; 2017():2534648. PubMed ID: 28298808
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
Zhou JH; Zhang B; Kernstine KH; Zhong L
World J Gastroenterol; 2011 Mar; 17(10):1373-8. PubMed ID: 21455340
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
20. Identification of glutathione S-transferase omega 1 (GSTO1) protein as a novel tumor-associated antigen and its autoantibody in human esophageal squamous cell carcinoma.
Li Y; Zhang Q; Peng B; Shao Q; Qian W; Zhang JY
Tumour Biol; 2014 Nov; 35(11):10871-7. PubMed ID: 25085586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
